Literature DB >> 19340910

Guillain-Barré syndrome following hepatitis E.

Jean Philippe Loly1, Estelle Rikir, Maxime Seivert, Emile Legros, Pierre Defrance, Jacques Belaiche, Gustave Moonen, Jean Delwaide.   

Abstract

Guillain-Barré syndrome (GBS) is often triggered by a preceding bacterial or viral infection. Occasionally, it has been observed in association with acute hepatitis A, B and C, and three cases have been previously described in India in which GBS was associated with acute hepatitis E. A molecular mimicry mechanism is supposed to be involved in the pathogenesis of GBS triggered by infectious agents, although the nature of the shared epitopes has not been characterized in most instances, including that in the case of hepatotropic viruses. We report a case of GBS following acute hepatitis E in a European individual. The presence of antiganglioside GM2 antibodies in this patient suggested molecular mimicry involving ganglioside GM2 in the pathogenesis of GBS associated with hepatitis E.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340910      PMCID: PMC2669950          DOI: 10.3748/wjg.15.1645

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases.

Authors:  Robert K Yu; Seigo Usuki; Toshio Ariga
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

2.  Guillain-Barre syndrome associated with acute hepatitis E.

Authors:  Praful Kamani; Rajiv Baijal; Deepak Amarapurkar; Parijat Gupte; Nikhil Patel; Praveen Kumar; Subhash Agal
Journal:  Indian J Gastroenterol       Date:  2005 Sep-Oct

3.  Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A.

Authors:  Jean-Marie Péron; Jean-Michel Mansuy; Hélène Poirson; Christophe Bureau; Emmanuel Dupuis; Laurent Alric; Jacques Izopet; Jean-Pierre Vinel
Journal:  Gastroenterol Clin Biol       Date:  2006-05

Review 4.  Ganglioside mimicry as a cause of Guillain-Barré syndrome.

Authors:  Tomoko Komagamine; Nobuhiro Yuki
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 5.  Guillain-Barré syndrome.

Authors:  Richard A C Hughes; David R Cornblath
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

6.  Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.

Authors:  J M Péron; C Bureau; H Poirson; J M Mansuy; L Alric; J Selves; E Dupuis; J Izopet; J P Vinel
Journal:  J Viral Hepat       Date:  2007-05       Impact factor: 3.728

Review 7.  Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

Authors:  N Yuki
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

8.  High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.

Authors:  Jean Michel Mansuy; Florence Legrand-Abravanel; Jean Pierre Calot; Jean Marie Peron; Laurent Alric; Sylvie Agudo; Henri Rech; François Destruel; Jacques Izopet
Journal:  J Med Virol       Date:  2008-02       Impact factor: 2.327

Review 9.  Guillain-Barré syndrome: epidemiology, pathophysiology and management.

Authors:  Satoshi Kuwabara
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.

Authors:  M Herremans; J Bakker; E Duizer; H Vennema; M P G Koopmans
Journal:  Clin Vaccine Immunol       Date:  2007-03-14
View more
  26 in total

Review 1.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  Hepatitis E with Gullain-Barré syndrome: still a rare association.

Authors:  Bhawna Sharma; Kadam Nagpal; Raghavendra Bakki Sannegowda; Swayam Prakash
Journal:  J Neurovirol       Date:  2013-03-08       Impact factor: 2.643

3.  First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection.

Authors:  I Maurissen; A Jeurissen; T Strauven; D Sprengers; B De Schepper
Journal:  Infection       Date:  2011-08-30       Impact factor: 3.553

Review 4.  Chronic hepatitis e virus infection and treatment.

Authors:  Nassim Kamar; Jacques Izopet; Harry R Dalton
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

Review 5.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

Review 6.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 7.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

8.  A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy.

Authors:  Sung Bok Ji; Sang Soo Lee; Hee Cheul Jung; Hong Jun Kim; Hyun Jin Kim; Tae Hyo Kim; Woon Tae Jung; Ok Jae Lee; Dae Hyun Song
Journal:  Clin Mol Hepatol       Date:  2016-08-30

9.  Transverse myelitis caused by hepatitis E: previously undescribed in adults.

Authors:  Pamela Sarkar; Catherine Morgan; Samreen Ijaz
Journal:  BMJ Case Rep       Date:  2015-07-06

Review 10.  Epidemiology of hepatitis E virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.